Press releases
- Silence Therapeutics to Present at Jefferies Global Healthcare Conference
- Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
- Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
- Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
- Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
More ▼
Key statistics
As of last trade Silence Therapeutics PLC (XRP2:DUS) traded at 17.20, 3.61% above its post-IPO low of 16.60, set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.30 |
---|---|
High | 17.30 |
Low | 17.20 |
Bid | 17.20 |
Offer | 17.90 |
Previous close | 17.60 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 19 2024 18:32 BST.
More ▼